Physician Education: Bridging Clinical Research and Patient Care

Sexually Transmitted Infections in the HIV-Infected Patient

Take Course

NOTE: Scroll to the bottom of the page and click "START COURSE" to begin.

Overview

CME Credit Available: 1.75 AMA PRA Category 1 Credits™
Level: Advanced
Release Date: April 18, 2012
Date of Last Review/Update: July 21, 2016
Expiration Date: July 21, 2017

This Cases on the Web activity describes a case and presents various clinical decision points, each focusing on an HIV-infected man with another possible sexually transmitted infection (STI).

At each decision point, participants should select the option that they think is most sound and then read the presenter’s explanation of that option. Selecting the correct option links the participant to an extended discussion of the related medical findings, research-based evidence, and case management considerations.

To advance from one clinical decision point to the next, participants should click on the NEXT button located at the bottom of the page that discusses the best clinical option.

After reviewing the cases, participants may access the activity posttest and the course evaluation, both of which must be completed and submitted to claim continuing medical education (CME) credit or a certificate of participation or continuing education units (CEUs) or pharmacy credits. Please see the posttest form and course evaluation form for further instructions.

Learning Objectives

On completion of this activity, participants will be able to:

  • Describe the approach to routine screening for STIs in the HIV-infected patient
  • Determine the management of gonococcal infections in the context of rising antimicrobial resistance
  • Delineate strategies for treatment of sex partners of persons with STIs and HIV infection
  • Identify emerging challenges in managing STIs among HIV-infected persons

Assessment of Needs

The IAS–USA offers this state-of-the-art activity as part of a nationwide CME effort for HIV physicians on the evolving challenges of HIV disease. This activity examines issues relevant to the treatment of HIV-infected patients with other STIs.

Intended Audience

This enduring material is designed for physicians who are actively treating or will be treating patients with HIV infection.

This activity is also relevant for other practitioners, including nurse practitioners, nurses, physician assistants, pharmacists, and others.

CME Information

Accreditation

The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation Statement

The IAS–USA designates this enduring material for a maximum of 1.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This CME activity is offered from July 21, 2016, to July 21, 2017. Physicians (MDs, DOs, and international equivalents) who successfully complete the activity posttest and submit the evaluation and registration forms are eligible to receive CME credit. Other health care practitioners will receive a Certificate of Participation.

Nursing Continuing Education Contact Hours

Educational Review Systems is an approved approver of continuing nursing education by the Alabama State Nursing Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.  Provider # 5-115.  This program is approved for 1.5 hours of continuing nursing education.

Educational Review Systems is also approved for nursing continuing education by the state of California, the state of Florida and the District of Columbia.

Program expires 7/21/2019

Pharmacy Continuing Education Contact Hours

Accreditation Council for Pharmacy Education logo

Educational Review Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This program is approved for 1.75 hour (0.175 CEUs) of continuing pharmacy education credit.  Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test.   Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit.

UAN  # 0761-9999-16-159-H01-P; 0761-9999-16-159-H01-P

Program expires 7/21/2019

Faculty

Author

Linda M. Gorgos, MD, MSc, FIDSA
Dr Gorgos is an HIV clinician with Special Immunology Associates at El Rio Community Health Center in Tucson, Arizona. She is board certified in Infectious Disease and completed a postdoctoral fellowship in prevention of sexually transmitted diseases, with a special interest in STIs and sexual health among minority populations. As a clinician in the fields of infectious disease and public health, Dr Gorgos focuses on the integration of care and prevention services regarding STIs, HIV, and viral hepatitis.

Editor

Jeanne M. Marrazzo, MD, MPH, FACP, FIDSA
Dr Marrazzo is Professor of Medicine at the University of Alabama at Birmingham. A fellow of the American College of Physicians and the Infectious Disease Society of America, Dr Marrazzo is also an investigator in the Microbicide Trials Network and has led clinical trials evaluating the role of preexposure prophylaxis to prevent HIV acquisition in women in sub-Saharan Africa.

Disclosure of Financial Interests

In the interest of maintaining the independence of its CME activities, and in accordance with the policies of the Accreditation Council for Continuing Medical Education, the IAS–USA requires all persons with control of content (eg, course faculty, IAS–USA Board members, and program staff) to disclose any financial relationships that they or their spouses or partners have had with commercial companies within the previous 12 months. Any real or apparent conflicts of interest of those parties are resolved prior to the CME activity being delivered. Individuals who refuse to disclose financial interests may not participate in an IAS–USA CME activity.

Faculty

Dr Gorgos has no relevant financial interests to disclose. (Updated 07/13/2016)

Dr Marrazzo has received has received research support from Cepheid and Merck & Co, Inc, and has served as a consultant for Cepheid. (Updated 04/10/2016)

Grant Support

This activity is part of the IAS–USA national educational effort that is funded, in part, by charitable contributions from commercial companies. Per IAS–USA policy, any effort that uses commercial grants must receive grants from several companies with competing products. Funds are pooled and distributed to activities at the sole discretion of the IAS–USA. Grantors have no input into any activity, including its content, development, or selection of topics or speakers. Generous support for this activity has been received from the following contributors.

2016 Grant Support

For our HIV effort:

  • Platinum Supporter
    ViiV Healthcare

  • Silver Supporters
    Bristol-Myers Squibb
    Gilead Sciences, Inc
    Janssen Therapeutics
    Merck & Co, Inc

For our viral hepatitis effort:

  • Gold Supporter
    Merck & Co, Inc

  • Silver Supporter
    Gilead Sciences, Inc

  • Bronze Supporter
    AbbVie

Cases on the Web Editorial Board

Members of the COW Editorial Board participate in a volunteer capacity. They are not compensated for their role in overseeing the program. Listed below are the COW Editorial Board members and their financial interests with commercial companies within the past 12 months from the date of disclosure. Click here to view the COW Editorial Board.

Drug and Product Disclaimer

This activity may contain information about the investigational uses of drugs or products that are not approved by the US Food and Drug Administration. Please consult full prescribing information before using any medication or product mentioned in this COW activity.

The views and opinions expressed herein are those of the faculty and do not necessarily represent the opinions or recommendations of the IAS–USA.

Contact Information

If you have any questions about this COW activity, please contact the IAS–USA:

IAS–USA
425 California Street
Suite 1450
San Francisco, CA 94104-2120
Telephone: 415-544-9400
Fax: 415-544-9401
E-mail: info“at”iasusa.org

Start Course

Course outline

Sexually Transmitted Infections in the HIV-Infected Patient

  • Overview
  • Case 1: A 32-Year-Old HIV-Infected Man Presents for Ongoing HIV Care
  • Case Presentation (Continued)
  • COW References
  • CME Post test
  • Evaluation